Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer

Johanna Bendell, Mansoor Saleh, April A.N. Rose, Peter M. Siegel, Lowell Hart, Surendra Sirpal, Suzanne Jones, Jennifer Green, Elizabeth Crowley, Ronit Simantov, Tibor Keler, Thomas Davis, Linda Vahdat

Research output: Contribution to journalArticlepeer-review

92 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science